Join to access to all OVN content. Join for Free
Lead with Strengths… Develop Your Weaknesses
personal strengths career growth job satisfaction positive psychology altercasting

Lead with Strengths… Develop Your Weaknesses


Share This Article


Summary

In this episode, Tom Caravela explores the importance of recognizing and utilizing personal strengths in both professional and personal realms. He shares research on the benefits of focusing on strengths over weaknesses and offers guidance on identifying and leveraging these in resumes and interviews. Tom also provides strategies for career growth and job satisfaction, including managerial tips for nurturing employee strengths. The concept of altercasting is introduced, encouraging listeners to apply their strengths daily while acknowledging areas for growth. The episode wraps up with a recap and a call to action for listener engagement and sharing.

Tom Caravela, Managing Partner at The Carolan Group, discusses why it is important to Lead with Strengths and Develop Your Weaknesses

Tom shares…

👉 Positive psychology research about success from using your strengths
👉 Why it is important to identify your strengths
👉 Examples of how strengths should be used throughout your career
👉 How to use your strengths in your personal life
👉 How and why it is important to develop your weaknesses

Click for Source
personal strengths, career growth, job satisfaction, positive psychology, altercasting

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
How to Leverage YOUR Unique Skills for Career Advantage
Partner Avatar MSL Talk: Tom Caravela, Hahn-Ey Lee

How to Leverage YOUR Unique Skills for Career Advantage

Podcast
Market Access and the MSL Role
Partner Avatar MSL Talk: Tom Caravela, Ruchit Parikh

Market Access and the MSL Role

Article
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
OVN Avatar S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Article
Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?
OVN Avatar Karen Geary

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

Explore OVN